Old Web
English
Sign In
Acemap
>
Paper
>
Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.
Publisher Correction: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.
2020
You Lu
Jianxin Xue
Tao Deng
Xiaojuan Zhou
Kun Yu
Lei Deng
Meijuan Huang
Xin Yi
Mao-zhi Liang
Yu Wang
Haige Shen
Ruizhan Tong
Wenbo Wang
Li Li
Jin Song
Jing Li
Xiaoxing Su
Zhenyu Ding
Youling Gong
Jiang Zhu
Yongsheng Wang
Bingwen Zou
Yan Zhang
Yanying Li
Lin Zhou
Yongmei Liu
Min Yu
Yuqi Wang
X. Zhang
Limei Yin
Xuefeng Xia
Yong Zeng
Qiao Zhou
Binwu Ying
Chong Chen
Yuquan Wei
Weimin Li
Tony Mok
Keywords:
Medicine
Cancer research
Refractory
Lung cancer
CRISPR
in patient
Immunology
non small cell
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]